PIK3CA encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3K), which is among the most commonly mutated and amplified genes in HNSCC and other cancers, and PI3K signaling is the most frequently altered oncogenic pathway [18,19,20]. This evidence concerns the gene PIK3CA and cancer.